BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
(NASDAQ: BTAI) Delayed: 1.27 -0.03 (2.31%)
Previous Close $1.30    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.31    P/E N/A 
Day Low $1.27    EPS $ 
Volume 220,833       

(NASDAQ: BTAI) Delayed: 1.27 -0.03 (2.31%)
Previous Close $1.30    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.31    P/E N/A 
Day Low $1.27    EPS $ 
Volume 220,833